The size of the Asia Pacific Ocular Implants Market is expected to grow at a healthy CAGR between 2021 to 2026.
Ocular implants are medical devices which are used for vision correction. Various forms of implants are available in the market and each one of them caters to a certain deficiency. Most of the implants are made from high grade plastic and are many a times compatible to the eye.
Increased prevalence of cataract and growing geriatric population is further driving the market growth. Various technological advancements and the growing demand of aesthetics among the younger population are further driving the market growth. However, people are still apprehensive to use it because of the side effects associated with it. Lack of skilled professionals are further hampering the market growth.
The market for Ocular Implants is broadly categorized into implant type, application and end user. By implant type the market is divided into intraocular lenses, corneal implants, glaucoma implants, orbital implants, ocular prosthesis, others. Glaucoma implants segment holds a major share of the market revenue. By application the market is divided into glaucoma surgery, oculoplasty, drug delivery, age related macular degeneration, aesthetic purpose and others. Glaucoma surgery segment segment accounts for a considerable market share. By end user the market is classified into hospitals, specialty eye clinics and eye institutes. On the basis of geography, the market is analysed under various regions namely China, India, Japan, Australia and South Korea. Asia Pacific is expected to grow at a high CAGR.
Some of the major companies dominating the market, by their products and services include Bausch & Lomb, Alcon, Carl Zeiss, Johnson & Johnson, MORCHER GmbH, and STAAR surgical.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Implant type
5.1.1 Introduction
5.1.2 Intraocular lenses
5.1.3 Corneal implants
5.1.4 Glaucoma implants
5.1.5 Orbital implants
5.1.6 Ocular prosthesis
5.1.7 Others
5.1.8 Y-o-Y Growth Analysis, By implant type
5.1.9 Market Attractiveness Analysis, By implant type
5.1.10 Market Share Analysis, By implant type
5.2 application
5.2.1 Introduction
5.2.2 Glaucoma surgery
5.2.3 Oculoplasty
5.2.4 Drug delivery
5.2.5 Age related macular degeneration
5.2.6 Aesthetic purpose
5.2.7 Others
5.2.8 Y-o-Y Growth Analysis, By application
5.2.9 Market Attractiveness Analysis, By application
5.2.10 Market Share Analysis, By application
5.3 End user
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Specialty eye clinics
5.3.4 Eye institutes
5.3.5 Y-o-Y Growth Analysis, By end user
5.3.6 Market Attractiveness Analysis, By end user
5.3.7 Market Share Analysis, By end user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Implant type
6.1.3.3 By application
6.1.3.4 By end user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By implant
6.1.4.3 By application
6.1.4.4 By end user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By implant
6.1.5.3 By application
6.1.5.4 By end user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Johnson & Johnson Services, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Alcon
8.3 Bausch & Lomb Incorporated
8.4 Pfizer Inc.
8.5 STAAR SURGICAL
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
